期刊
ADVANCED HEALTHCARE MATERIALS
卷 5, 期 16, 页码 2055-2068出版社
WILEY
DOI: 10.1002/adhm.201600263
关键词
bispecific antibodies; epidermal growth factor receptor; poly(ethylene glycol); polymers; targeted nanomaterials
资金
- National Health and Medical Research Council [APP1046831]
- Australian Research Council [FT110100284, DP140100951]
- National Breast Cancer Foundation
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology [CE140100036]
- National Breast Cancer Foundation [NC-14-037] Funding Source: researchfish
Targeted nanomaterials promise improved therapeutic efficacy, however their application in nanomedicine is limited due to complexities associated with protein conjugations to synthetic nanocarriers. A facile method to generate actively targeted nanomaterials is developed and exemplified using polyethylene glycol (PEG)-functional nanostructures coupled to a bispecific antibody (BsAb) with dual specificity for methoxy PEG (mPEG) epitopes and cancer targets such as epidermal growth factor receptor (EGFR). The EGFR-mPEG BsAb binds with high affinity to recombinant EGFR (K-D: 1 x 10(-9)m) and hyperbranched polymer (HBP) consisting of mPEG (K-D: 10 x 10(-9)m) and demonstrates higher avidity for HBP compared to linear mPEG. The binding of BsAb-HBP bioconjugate to EGFR on MDA-MB-468 cancer cells is investigated in vitro using a fluorescently labeled polymer, and in in vivo xenograft models by small animal optical imaging. The antibody-targeted nanostructures show improved accumulation in tumor cells compared to non-targeted nanomaterials. This demonstrates a facile approach for tuning targeting ligand density on nanomaterials, by modulating surface functionality. Antibody fragments are tethered to the nanomaterial through simple mixing prior to administration to animals, overcoming the extensive procedures encountered for developing targeted nanomedicines.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据